![Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics](https://pubs.rsna.org/cms/10.1148/rg.2021210005/asset/images/medium/rg.2021210005.va.gif)
Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics
![Predictive effects of preoperative serum CA125 and AFP levels on post‑hepatectomy survival in patients with hepatitis B‑related hepatocellular carcinoma Predictive effects of preoperative serum CA125 and AFP levels on post‑hepatectomy survival in patients with hepatitis B‑related hepatocellular carcinoma](https://www.spandidos-publications.com/article_images/ol/21/6/ol-21-06-12748-g00.jpg)
Predictive effects of preoperative serum CA125 and AFP levels on post‑hepatectomy survival in patients with hepatitis B‑related hepatocellular carcinoma
![Frontiers | Stratification of ovarian cancer borderline from high-grade serous carcinoma patients by quantitative serum NMR spectroscopy of metabolites, lipoproteins, and inflammatory markers Frontiers | Stratification of ovarian cancer borderline from high-grade serous carcinoma patients by quantitative serum NMR spectroscopy of metabolites, lipoproteins, and inflammatory markers](https://www.frontiersin.org/files/Articles/1158330/fmolb-10-1158330-HTML-r2/image_m/fmolb-10-1158330-g001.jpg)
Frontiers | Stratification of ovarian cancer borderline from high-grade serous carcinoma patients by quantitative serum NMR spectroscopy of metabolites, lipoproteins, and inflammatory markers
![IJMS | Free Full-Text | Methods for Identification of CA125 from Ovarian Cancer Ascites by High Resolution Mass Spectrometry IJMS | Free Full-Text | Methods for Identification of CA125 from Ovarian Cancer Ascites by High Resolution Mass Spectrometry](https://www.mdpi.com/ijms/ijms-13-09942/article_deploy/html/images/ijms-13-09942f1.png)
IJMS | Free Full-Text | Methods for Identification of CA125 from Ovarian Cancer Ascites by High Resolution Mass Spectrometry
![Change in CA 125 levels after the first cycle of induction chemotherapy is an independent predictor of epithelial ovarian tumour outcome - ScienceDirect Change in CA 125 levels after the first cycle of induction chemotherapy is an independent predictor of epithelial ovarian tumour outcome - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0923753419420218-gr1.jpg)
Change in CA 125 levels after the first cycle of induction chemotherapy is an independent predictor of epithelial ovarian tumour outcome - ScienceDirect
![Frontiers | High Serum Carbohydrate Antigen (CA) 125 Level Is Associated With Poor Prognosis in Patients With Light-Chain Cardiac Amyloidosis Frontiers | High Serum Carbohydrate Antigen (CA) 125 Level Is Associated With Poor Prognosis in Patients With Light-Chain Cardiac Amyloidosis](https://www.frontiersin.org/files/Articles/692083/fcvm-08-692083-HTML/image_m/fcvm-08-692083-g002.jpg)
Frontiers | High Serum Carbohydrate Antigen (CA) 125 Level Is Associated With Poor Prognosis in Patients With Light-Chain Cardiac Amyloidosis
![Combined score of pretreatment platelet count and CA125 level (PLT-CA125) stratified prognosis in patients with FIGO stage IV epithelial ovarian cancer | Journal of Ovarian Research | Full Text Combined score of pretreatment platelet count and CA125 level (PLT-CA125) stratified prognosis in patients with FIGO stage IV epithelial ovarian cancer | Journal of Ovarian Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13048-019-0544-y/MediaObjects/13048_2019_544_Fig1_HTML.png)
Combined score of pretreatment platelet count and CA125 level (PLT-CA125) stratified prognosis in patients with FIGO stage IV epithelial ovarian cancer | Journal of Ovarian Research | Full Text
![The National Institute for Health and Clinical Excellence (NICE) guidelines for early detection of ovarian cancer: the pivotal role of the clinical laboratory - Catharine M Sturgeon, Michael J Duffy, Graeme Walker, The National Institute for Health and Clinical Excellence (NICE) guidelines for early detection of ovarian cancer: the pivotal role of the clinical laboratory - Catharine M Sturgeon, Michael J Duffy, Graeme Walker,](https://journals.sagepub.com/cms/10.1258/acb.2011.011117/asset/images/large/10.1258_acb.2011.011117-fig1.jpeg)
The National Institute for Health and Clinical Excellence (NICE) guidelines for early detection of ovarian cancer: the pivotal role of the clinical laboratory - Catharine M Sturgeon, Michael J Duffy, Graeme Walker,
The diagnostic performance of CA125 for the detection of ovarian and non-ovarian cancer in primary care: A population-based cohort study | PLOS Medicine
![CA125 test result, test-to-diagnosis interval, and stage in ovarian cancer at diagnosis: a retrospective cohort study using electronic health records | British Journal of General Practice CA125 test result, test-to-diagnosis interval, and stage in ovarian cancer at diagnosis: a retrospective cohort study using electronic health records | British Journal of General Practice](https://bjgp.org/content/bjgp/71/707/e465/F1.large.jpg)
CA125 test result, test-to-diagnosis interval, and stage in ovarian cancer at diagnosis: a retrospective cohort study using electronic health records | British Journal of General Practice
![Cancers | Free Full-Text | Preoperative Cancer Antigen 125 Level as Predictor for Complete Cytoreduction in Ovarian Cancer: A Prospective Cohort Study and Systematic Review Cancers | Free Full-Text | Preoperative Cancer Antigen 125 Level as Predictor for Complete Cytoreduction in Ovarian Cancer: A Prospective Cohort Study and Systematic Review](https://pub.mdpi-res.com/cancers/cancers-14-05734/article_deploy/html/images/cancers-14-05734-g001.png?1669281609)
Cancers | Free Full-Text | Preoperative Cancer Antigen 125 Level as Predictor for Complete Cytoreduction in Ovarian Cancer: A Prospective Cohort Study and Systematic Review
![IJMS | Free Full-Text | Methods for Identification of CA125 from Ovarian Cancer Ascites by High Resolution Mass Spectrometry IJMS | Free Full-Text | Methods for Identification of CA125 from Ovarian Cancer Ascites by High Resolution Mass Spectrometry](https://www.mdpi.com/ijms/ijms-13-09942/article_deploy/html/images/ijms-13-09942f3a.png)
IJMS | Free Full-Text | Methods for Identification of CA125 from Ovarian Cancer Ascites by High Resolution Mass Spectrometry
![Cumulative ascites volume, tumor weight and CA125 levels at the end of... | Download Scientific Diagram Cumulative ascites volume, tumor weight and CA125 levels at the end of... | Download Scientific Diagram](https://www.researchgate.net/profile/Alan-Perkins/publication/51655731/figure/fig3/AS:340784567078920@1458260780501/Cumulative-ascites-volume-tumor-weight-and-CA125-levels-at-the-end-of-experiments-after_Q320.jpg)
Cumulative ascites volume, tumor weight and CA125 levels at the end of... | Download Scientific Diagram
![IJMS | Free Full-Text | Methods for Identification of CA125 from Ovarian Cancer Ascites by High Resolution Mass Spectrometry IJMS | Free Full-Text | Methods for Identification of CA125 from Ovarian Cancer Ascites by High Resolution Mass Spectrometry](https://www.mdpi.com/ijms/ijms-13-09942/article_deploy/html/images/ijms-13-09942f3b.png)
IJMS | Free Full-Text | Methods for Identification of CA125 from Ovarian Cancer Ascites by High Resolution Mass Spectrometry
![Mathematical modeling of the early modeled CA-125 longitudinal kinetics (KELIM-PARP) as a pragmatic indicator of rucaparib efficacy in patients with recurrent ovarian carcinoma in ARIEL2 & STUDY 10 - eBioMedicine Mathematical modeling of the early modeled CA-125 longitudinal kinetics (KELIM-PARP) as a pragmatic indicator of rucaparib efficacy in patients with recurrent ovarian carcinoma in ARIEL2 & STUDY 10 - eBioMedicine](https://www.thelancet.com/cms/attachment/362297e3-e465-4949-9cd3-f4e0a43c2525/gr2.jpg)
Mathematical modeling of the early modeled CA-125 longitudinal kinetics (KELIM-PARP) as a pragmatic indicator of rucaparib efficacy in patients with recurrent ovarian carcinoma in ARIEL2 & STUDY 10 - eBioMedicine
![Predictive effects of preoperative serum CA125 and AFP levels on post‑hepatectomy survival in patients with hepatitis B‑related hepatocellular carcinoma Predictive effects of preoperative serum CA125 and AFP levels on post‑hepatectomy survival in patients with hepatitis B‑related hepatocellular carcinoma](https://www.spandidos-publications.com/article_images/ol/21/6/ol-21-06-12748-g02.jpg)
Predictive effects of preoperative serum CA125 and AFP levels on post‑hepatectomy survival in patients with hepatitis B‑related hepatocellular carcinoma
![Novel 5-(2-phenylbenzo[b]thiophen-3-yl)furan-2-carbaldehyde based ovarian cancer carbohydrate antigen 125 electrochemical sensor - ScienceDirect Novel 5-(2-phenylbenzo[b]thiophen-3-yl)furan-2-carbaldehyde based ovarian cancer carbohydrate antigen 125 electrochemical sensor - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0254058422008665-ga1.jpg)
Novel 5-(2-phenylbenzo[b]thiophen-3-yl)furan-2-carbaldehyde based ovarian cancer carbohydrate antigen 125 electrochemical sensor - ScienceDirect
![Frontiers | High Serum Carbohydrate Antigen (CA) 125 Level Is Associated With Poor Prognosis in Patients With Light-Chain Cardiac Amyloidosis Frontiers | High Serum Carbohydrate Antigen (CA) 125 Level Is Associated With Poor Prognosis in Patients With Light-Chain Cardiac Amyloidosis](https://www.frontiersin.org/files/MyHome%20Article%20Library/692083/692083_Thumb_400.jpg)
Frontiers | High Serum Carbohydrate Antigen (CA) 125 Level Is Associated With Poor Prognosis in Patients With Light-Chain Cardiac Amyloidosis
![Frontiers | High Serum Carbohydrate Antigen (CA) 125 Level Is Associated With Poor Prognosis in Patients With Light-Chain Cardiac Amyloidosis Frontiers | High Serum Carbohydrate Antigen (CA) 125 Level Is Associated With Poor Prognosis in Patients With Light-Chain Cardiac Amyloidosis](https://www.frontiersin.org/files/Articles/692083/fcvm-08-692083-HTML/image_m/fcvm-08-692083-g001.jpg)
Frontiers | High Serum Carbohydrate Antigen (CA) 125 Level Is Associated With Poor Prognosis in Patients With Light-Chain Cardiac Amyloidosis
![The Association of Effluent CA125 with Peritoneal Dialysis Technique Failure - Deirisa Lopes Barreto, Tiny Hoekstra, Nynke Halbesma, Martijn Leegte, Elisabeth W. Boeschoten, Friedo W. Dekker, Raymond T. Krediet, 2015 The Association of Effluent CA125 with Peritoneal Dialysis Technique Failure - Deirisa Lopes Barreto, Tiny Hoekstra, Nynke Halbesma, Martijn Leegte, Elisabeth W. Boeschoten, Friedo W. Dekker, Raymond T. Krediet, 2015](https://journals.sagepub.com/cms/10.3747/pdi.2014.00016/asset/images/large/10.3747_pdi.2014.00016-fig1.jpeg)
The Association of Effluent CA125 with Peritoneal Dialysis Technique Failure - Deirisa Lopes Barreto, Tiny Hoekstra, Nynke Halbesma, Martijn Leegte, Elisabeth W. Boeschoten, Friedo W. Dekker, Raymond T. Krediet, 2015
![Extra-ordinary High Cancer antigen 125 (CA-125) level in a 41 year-old patient with adenomyosis – ISGE Extra-ordinary High Cancer antigen 125 (CA-125) level in a 41 year-old patient with adenomyosis – ISGE](https://www.isge.org/wp-content/uploads/2021/10/TheTrocar-Vol2-Iss3_3_featured.jpg)